Periodontal disease and rheumatoid arthritis: The evidence accumulates for complex pathobiologic interactions

Current Opinion in Rheumatology

Volumn 25, Issue 3, 2013, Pages 345-353

  Bingham, Clifton O ^a,b   Moni, Malini ^a  

^a Division of Rheumatology   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

citrullination; periodontal disease; periodontitis; Porphyromonas gingivalis; rheumatoid arthritis

Indexed keywords

DOXYCYCLINE; ENOLASE; FIBRINOGEN; INTEGRIN; INTERLEUKIN 6; METHOTREXATE; TUMOR NECROSIS FACTOR INHIBITOR; VIMENTIN;

ALVEOLAR BONE LOSS; AUTOIMMUNE DISEASE; BONE DESTRUCTION; CLINICAL FEATURE; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE SEVERITY; ENDOTHELIUM CELL; GENETIC RISK; GINGIVITIS; HUMAN; MOUTH DISEASE; NONHUMAN; PATHOGENESIS; PERIODONTAL DISEASE; PERIODONTITIS; PORPHYROMONAS GINGIVALIS; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; RHEUMATOID ARTHRITIS; SJOEGREN SYNDROME; XEROSTOMIA;

ANIMALS; ARTHRITIS, EXPERIMENTAL; ARTHRITIS, RHEUMATOID; BACTEROIDACEAE INFECTIONS; CITRULLINE; DISEASE MODELS, ANIMAL; EVIDENCE-BASED MEDICINE; HUMANS; PERIODONTAL DISEASES; PORPHYROMONAS GINGIVALIS;

EID: 84875907966     PISSN: 10408711     EISSN: 15316963     Source Type: Journal    
DOI: 10.1097/BOR.0b013e32835fb8ec     Document Type: Review

References (88)

1. McGraw WT, Potempa J, Farley D, Travis J. Purification, characterization, and sequence analysis of a potential virulence factor from porphyromonas gingivalis, peptidylarginine deiminase. Infect Immun 1999; 67:3248-3256.
2. Garib BT, Qaradaxi SS. Temporomandibular joint problems and periodontal condition in rheumatoid arthritis patients in relation to their rheumatologic status. J Oral Maxillofac Surg 2011; 69:2971-2978.
3. de Pablo P, Dietrich T, McAlindon TE. Association of periodontal disease and tooth loss with rheumatoid arthritis in the US population. J Rheumatol 2008; 35:70-76.
4. Mays JW, Sarmadi M, Moutsopoulos NM. Oral manifestations of systemic autoimmune and inflammatory diseases: diagnosis and clinical management. J Evid Based Dent Pract 2012; 12:265-282.
5. Haga HJ, Naderi Y, Moreno AM, Peen E. A study of the prevalence of sicca symptoms and secondary Sjogren's syndrome in patients with rheumatoid arthritis, and its association to disease activity and treatment profile. Int J Rheum Dis 2012; 15:284-288.
6. Antero DC, Parra AG, Miyazaki FH, et al. Secondary Sjogren's syndrome and disease activity of rheumatoid arthritis. Rev Assoc Med Bras 2011; 57:319-322.
7. Shiboski SC, Shiboski CH, Criswell L, et al. American College of Rheumatology classification criteria for Sjogren's syndrome: a data-driven, expert consensus approach in the Sjogren's International Collaborative Clinical Alliance cohort. Arthritis Care Res (Hoboken) 2012; 64:475-487.
8. Hackett KL, Newton JL, Frith J, et al. Impaired functional status in primary Sjogren's syndrome. Arthritis Care Res (Hoboken) 2012; 64:1760-1764.
9. Enger TB, Palm O, Garen T, et al. Oral distress in primary Sjogren's syndrome: implications for health-related quality of life. Eur J Oral Sci 2011; 119:474-480.
10. Jorkjend L, Johansson A, Johansson AK, Bergenholtz A. Periodontitis, caries and salivary factors in Sjogren's syndrome patients compared to sex-and agematched controls. J Oral Rehabil 2003; 30:369-378.
11. Kuru B, McCullough MJ, Yilmaz S, Porter SR. Clinical and microbiological studies of periodontal disease in Sjogren syndrome patients. J Clin Periodondol 2002; 29:92-102.
12. Antoniazzi RP, Miranda LA, Zanatta FB, et al. Periodontal conditions of individuals with Sjogren's syndrome. J Periodontol 2009; 80:429-435.
13. Kawar N, Gajendrareddy PK, Hart TC, et al. Periodontal disease for the primary care physician. Dis Mon 2011; 57:174-183.
14. Shanbhag S, Dahiya M, Croucher R. The impact of periodontal therapy on oral health-related quality of life in adults: a systematic review. J Clin Periodontol 2012; 39:725-735.
15. Dye BA. Global periodontal disease epidemiology. Periodontol 2000 2012; 58:10-25.
16. Eke PI, Dye BA, Wei L, et al. Prevalence of periodontitis in adults in the United States: 2009 and 2010. J Dental Res 2012; 91:914-920.
17. Eke PI, Thornton-EVans G, Dye B, Genco R. AdVances in surveillance of periodontitis: the Centers for Disease Control and prevention periodontal disease surveillance project. J Periodontol 2012; 83:1337-1342.
18. Eke PI, Thornton-EVans GO, Wei L, et al. Accuracy of NHANES periodontal examination protocols. J Dental Res 2010; 89:1208-1213.
19. Rutger Persson G. Rheumatoid arthritis and periodontitis: inflammatory and infectious connections: review of the literature. J Oral Microbiol 2012; 4:10.
20. Han JY, Reynolds MA. Effect of antirheumatic agents on periodontal parameters and biomarkers of inflammation: a systematic review and metaanalysis. J Periodontal Implant Sci 2012; 42:3-12.
21. Berthelot JM, Le Goff B. Rheumatoid arthritis and periodontal disease. Joint Bone Spine 2010; 77:537-541.
22. Arkema EV, Karlson EW, Costenbader KH. A prospective study of periodontal disease and risk of rheumatoid arthritis. J Rheumatol 2010; 37:1800-1804.
23. Demmer RT, Molitor JA, Jacobs DR Jr, Michalowicz BS. Periodontal disease, tooth loss and incident rheumatoid arthritis: results from the First National Health and Nutrition Examination Survey and its epidemiological follow-up study. J Clin Periodontol 2011; 38:998-1006.
24. Chen HH, Huang N, Chen YM, et al. Association between a history of periodontitis and the risk of rheumatoid arthritis: a nationwide, populationbased, case-control study. Ann Rheum Dis 2012. doi:10.1136/ annrheumdis-2012-201593
25. Dissick A, Redman RS, Jones M, et al. Association of periodontitis with rheumatoid arthritis: a pilot study. J Periodontol 2010; 81:223-230.
26. Potikuri D, Dannana KC, Kanchinadam S, et al. Periodontal disease is significantly higher in nonsmoking treatment-naive rheumatoid arthritis patients: results from a case-control study. Ann Rheum Dis 2012; 71: 1541-1544.
27. Abou-Raya S, Abou-Raya A, Naim A, Abuelkheir H. Rheumatoid arthritis, periodontal disease and coronary artery disease. Clin Rheumatol 2008; 27:421-427.
28. Kobayashi T, Murasawa A, Komatsu Y, et al. Serum cytokine and periodontal profiles in relation to disease activity of rheumatoid arthritis in Japanese adults. J Periodontol 2010; 81:650-657.
29. Erciyas K, Sezer U, Ustun K, et al. Effects of periodontal therapy on disease activity and systemic inflammation in rheumatoid arthritis patients. Oral Dis 2012. [Epub ahead of print] doi: 10.1111/odi.12017.
30. Ortiz P, Bissada NF, Palomo L, et al. Periodontal therapy reduces the severity of active rheumatoid arthritis in patients treated with or without tumor necrosis factor inhibitors. J Periodontol 2009; 80:535-540.
31. Al-Katma MK, Bissada NF, Bordeaux JM, et al. Control of periodontal infection reduces the severity of active rheumatoid arthritis. J Clin Rheum 2007; 13:134-137.
32. Pinho Mde N, Oliveira RD, Novaes AB Jr, Voltarelli JC. Relationship between periodontitis and rheumatoid arthritis and the effect of nonsurgical periodontal treatment. Braz Dent J 2009; 20:355-364.
33. O'Dell JR, Elliott JR, Mallek JA, et al. Treatment of early seropositive rheumatoid arthritis: doxycycline plus methotrexate versus methotrexate alone. Arthritis Rheum 2006; 54:621-627.
34. Savioli C, Ribeiro AC, Fabri GM, et al. Persistent periodontal disease hampers antitumor necrosis factor treatment response in rheumatoid arthritis. J Clin Rheum 2012; 18:180-184.
35. Mayer Y, Balbir-Gurman A, Machtei EE. Antitumor necrosis factor-alpha therapy and periodontal parameters in patients with rheumatoid arthritis. J Periodontol 2009; 80:1414-1420.
36. Pers JO, Saraux A, Pierre R, Youinou P. Anti-TNF-alpha immunotherapy is associated with increased gingival inflammation without clinical attachment loss in subjects with rheumatoid arthritis. J Periodonto 2008; 79:1645-1651.
37. Marotte H, Farge P, Gaudin P, et al. The association between periodontal disease and joint destruction in rheumatoid arthritis extends the link between the HLA-DR shared epitope and severity of bone destruction. Ann Rheum Dis 2006; 65:905-909.
38. Farquharson D, Butcher JP, Culshaw S. Periodontitis, Porphyromonas, and the pathogenesis of rheumatoid arthritis. Mucosal Immunol 2012; 5:112-120.
39. de Pablo P, Chapple IL, Buckley CD, Dietrich T. Periodontitis in systemic rheumatic diseases. Nat Rev Rheumatol 2009; 5:218-224.
40. Routsias JG, Goules JD, Goules A, et al. Autopathogenic correlation of periodontitis and rheumatoid arthritis. Rheumatology 2011; 50:1189-1193.
41. Rosenstein ED, Weissmann G, Greenwald RA. Porphyromonas gingivalis, periodontitis and rheumatoid arthritis. Med Hypotheses 2009; 73:457-458.
42. Rosenstein ED, Greenwald RA, Kushner LJ, Weissmann G. Hypothesis: the humoral immune response to oral bacteria provides a stimulus for the development of rheumatoid arthritis. Inflammation 2004; 28:311-318.
43. Greenwald RA, Kirkwood K. Adult periodontitis as a model for rheumatoid arthritis (with emphasis on treatment strategies). J Rheumatol 1999; 26: 1650-1653.
44. Culshaw S, McInnes IB, Liew FY. What can the periodontal community learn from the pathophysiology of rheumatoid arthritis J Clin Periodontol 2011; 38 (Suppl 11):106-113.
45. Moen K, Brun JG, Valen M, et al. Synovial inflammation in active rheumatoid arthritis and psoriatic arthritis facilitates trapping of a variety of oral bacterial DNAs. Clin Exp Rheumatol 2006; 24:656-663.
46. Bonfil JJ, Dillier FL, Mercier P, et al. A 'case control' study on the role of HLA DR4 in severe periodontitis and rapidly progressive periodontitis: identification of types and subtypes using molecular biology (PCR.SSO). J Clin Periodontol 1999; 26:77-84.
47. Firatli E, Kantarci A, Cebeci I, et al. Association between HLA antigens and early onset periodontitis. J Clin Periodontol 1996; 23:563-566.
48. Ishida K, Kobayashi T, Ito S, et al. Interleukin-6 gene promoter methylation in rheumatoid arthritis and chronic periodontitis. J Periodontol 2012; 83:917-925.
49. Hajishengallis G, Lamont RJ. Beyond the red complex and into more complexity: the polymicrobial synergy and dysbiosis (PSD) model of periodontal disease etiology. Mol Oral Microbiol 2012; 27:409-419.
50. Wade WG. Has the use of molecular methods for the characterization of the human oral microbiome changed our understanding of the role of bacteria in the pathogenesis of periodontal disease J Clin Periodontol 2011; 38 (Suppl 11):7-16.
51. Bostanci N, Belibasakis GN. Porphyromonas gingivalis: an invasive and evasive opportunistic oral pathogen. FEMS microbiology letters 2012; 333:1-9.
52. Detert J, Pischon N, Burmester GR, Buttgereit F. The association between rheumatoid arthritis and periodontal disease. Arthritis Res Ther 2010; 12: 218.
53. Sheets SM, Robles-Price AG, McKenzie RM, et al. Gingipain-dependent interactions with the host are important for survival of Porphyromonas gingivalis. Front Biosci 2008; 13:3215-3238.
54. Rohner E, Hoff P, Matziolis G, et al. The impact of Porphyromonas gingivalis lipids on apoptosis of primary human chondrocytes. Conn Tis Res 2012; 53:327-333.
55. Hayashi C, Gudino CV, Gibson FC 3rd, Genco CA. Review: Pathogeninduced inflammation at sites distant from oral infection: bacterial persistence and induction of cell-specific innate immune inflammatory pathways. Mol Oral Micro 2010; 25:305-316.
56. Hoovestol RA, Mikuls TR. Environmental exposures and rheumatoid arthritis risk. Curr Rheum Rep 2011; 13:431-439.
57. Mikuls TR. Help stop tooth decay.and prevent RA J Rheumatol 2010; 37:1083-1085.
58. Mikuls TR, Payne JB, Reinhardt RA, et al. Antibody responses to Porphyromonas gingivalis (P. gingivalis) in subjects with rheumatoid arthritis and periodontitis. Int Immunopharmacol 2009; 9:38-42.
59. Okada M, Kobayashi T, Ito S, et al. Antibody responses to periodontopathic bacteria in relation to rheumatoid arthritis in Japanese adults. J Periodontol 2011; 82:1433-1441.
60. Ziebolz D, Pabel SO, Lange K, et al. Clinical periodontal and microbiologic parameters in patients with rheumatoid arthritis. J Periodontol 2011; 82:1424-1432.
61. Smit MD, Westra J, Vissink A, et al. Periodontitis in established rheumatoid arthritis patients: a cross-sectional clinical, microbiological and serological study. Arthritis Res Ther 2012; 14:R222.
62. Mikuls TR, Thiele GM, Deane KD, et al. Porphyromonas gingivalis and disease-related autoantibodies in individuals at increased risk of rheumatoid arthritis. Arthritis Rheum 2012; 64:3522-3530.
63. Hitchon CA, Chandad F, Ferucci ED, et al. Antibodies to porphyromonas gingivalis are associated with anticitrullinated protein antibodies in patients with rheumatoid arthritis and their relatives. J Rheumatol 2010; 37:1105-1112.
64. Scher JU, Ubeda C, Equinda M, et al. Periodontal disease and the oral microbiota in new-onset rheumatoid arthritis. Arthritis Rheum 2012; 64:3083-3094.
65. Rodriguez SB, Stitt BL, Ash DE. Expression of peptidylarginine deiminase from Porphyromonas gingivalis in Escherichia coli: enzyme purification and characterization. Arch Biochem Biophys 2009; 488:14-22.
66. Vossenaar ER, Zendman AJ, Van Venrooij WJ, Pruijn GJ. PAD, a growing family of citrullinating enzymes: genes, features and involvement in disease. Bioessays 2003; 25:1106-1118.
67. Mangat P, Wegner N, Venables PJ, Potempa J. Bacterial and human peptidylarginine deiminases: targets for inhibiting the autoimmune response in rheumatoid arthritis Arthritis Res Ther 2010; 12:209.
68. Andrade F, Darrah E, Gucek M, et al. Autocitrullination of human peptidyl arginine deiminase type 4 regulates protein citrullination during cell activation. Arthritis Rheum 2010; 62:1630-1640.
69. Darrah E, Rosen A, Giles JT, Andrade F. Peptidylarginine deiminase 2, 3 and 4 have distinct specificities against cellular substrates: novel insights into autoantigen selection in rheumatoid arthritis. Ann Rheum Dis 2012; 71:92-98.
70. Wegner N, Lundberg K, Kinloch A, et al. Autoimmunity to specific citrullinated proteins gives the first clues to the etiology of rheumatoid arthritis. Immunol Rev 2010; 233:34-54.
71. Snir O, Widhe M, von Spee C, et al. Multiple antibody reactivities to citrullinated antigens in sera from rheumatoid arthritis patients: association with HLA-DRB1 alleles. Ann Rheum Dis 2009; 68:736-743.
72. Snir O, Widhe M, Hermansson M, et al. Antibodies to several citrullinated antigens are enriched in the joints of rheumatoid arthritis patients. Arthritis Rheum 2010; 62:44-52.
73. Lundberg K, Kinloch A, Fisher BA, et al. Antibodies to citrullinated alphaenolase peptide 1 are specific for rheumatoid arthritis and cross-react with bacterial enolase. Arthritis Rheum 2008; 58:3009-3019.
74. Wegner N, Wait R, Sroka A, et al. Peptidylarginine deiminase from Porphyromonas gingivalis citrullinates human fibrinogen and alpha-enolase: implications for autoimmunity in rheumatoid arthritis. Arthritis Rheum2010; 62:2662-2672.
75. Lundberg K, Wegner N, Yucel-Lindberg T, Venables PJ. Periodontitis in RAthe citrullinated enolase connection. Nat Rev Rheumatol 2010; 6:727-730.
76. Pyrc K, Milewska A, Kantyka T, et al. Inactivation of epidermal growth factor by Porphyromonas gingivalis as a potential mechanism for periodontal tissue damage. Infect Immun 2013; 81:55-64.
77. Harvey GP, Fitzsimmons TR, Dhamarpatni AA, et al. Expression of peptidylarginine deiminase-2 and-4, citrullinated proteins and anticitrullinated protein antibodies in human gingiva. J Periodontol Res 2013; 25:241-247.
78. Makrygiannakis D, Hermansson M, Ulfgren AK, et al. Smoking increases peptidylarginine deiminase 2 enzyme expression in human lungs and increases citrullination in BAL cells. Ann Rheum Dis 2008; 67:1488-1492.
79. Nesse W, Westra J, Van der Wal JE, et al. The periodontium of periodontitis patients contains citrullinated proteins which may play a role in ACPA (anticitrullinated protein antibody) formation. J Clin Periodontol 2012; 39:599-607.
80. Bartold PM, Marino V, Cantley M, Haynes DR. Effect of Porphyromonas gingivalis-induced inflammation on the development of rheumatoid arthritis. J Clin Periodontol 2010; 37:405-411.
81. Ramamurthy NS, Greenwald RA, Celiker MY, Shi EY. Experimental arthritis in rats induces biomarkers of periodontitis which are ameliorated by gene therapy with tissue inhibitor of matrix metalloproteinases. J Periodontol 2005; 76:229-233.
82. Queiroz-Junior CM, Madeira MF, Coelho FM, et al. Experimental arthritis triggers periodontal disease in mice: involvement of TNF-alpha and the oral Microbiota. J Immunol 2011; 187:3821-3830.
83. Queiroz-Junior CM, Madeira MF, Coelho FM, et al. Experimental arthritis exacerbates Aggregatibacter actinomycetemcomitans-induced periodontitis in mice. J Clin Periodontol 2012; 39:608-616.
84. Cantley MD, Haynes DR, Marino V, Bartold PM. Preexisting periodontitis exacerbates experimental arthritis in a mouse model. J Clin Periodontol 2011; 38:532-541.
85. Park JC, Su C, Jung IH, et al. Mechanism of alveolar bone loss in a collageninduced arthritis model in mice. J Clin Periodontol 2011; 38:122-130.
86. Kinloch AJ, Alzabin S, Brintnell W, et al. Immunization with Porphyromonas gingivalis enolase induces autoimmunity to mammalian alpha-enolase and arthritis in DR4-IE-transgenic mice. Arthritis Rheum 2011; 63:3818-3823.
87. Hill JA, Bell DA, Brintnell W, et al. Arthritis induced by posttranslationally modified (citrullinated) fibrinogen in DR4-IE transgenic mice. J Exp Med 2008; 205:967-979.
88. Haag S, Uysal H, Backlund J, et al. Human alpha-enolase is immunogenic, but not arthritogenic, in HLA-DR4-transgenic mice: comment on the article by Kinloch et al. Arthritis Rheum 2012; 64:1689-1691; author reply 1691-1682.